Product description
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol is a compound also called CMS121. The compound's structural complexity suggests it may have unique properties and potential uses. To understand its importance, it helps to identify the functional groups present and analyze their potential impact. The presence of the quinoline ring suggests that the compound may be biologically active. Quinoline-derived molecules are known for their diverse biological properties, including antibacterial and anti-inflammatory activities. Attachment of the cyclopentyloxy group may contribute to the solubility of the compound or enhance its biological activity through steric effects. In studies on HT22 cells, CMS-121 has demonstrated significant neuroprotective effects, effectively protecting these cells from ischemia and oxidative damage. Furthermore, CMS-121 has significant anti-inflammatory properties, indicating its ability to modulate inflammatory responses. By doing so, CMS-121 has the potential to reduce inflammation in various tissues and organs. CMS-121 has strong pharmacological activity as an inhibitor of acetyl-CoA carboxylase 1 (ACC1). Its potent inhibitory effect on ACC1 makes it a promising compound.
Read more